Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8917 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD7768 |
Phase 2 |
0.86 |
High Similarity |
NPD1510 |
Phase 2 |
0.8544 |
High Similarity |
NPD4380 |
Phase 2 |
0.8528 |
High Similarity |
NPD6959 |
Discontinued |
0.8491 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8462 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8344 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8232 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8165 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8137 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7975 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7941 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7904 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7848 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7765 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7716 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7706 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7684 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7684 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7683 |
Intermediate Similarity |
NPD5403 |
Approved |
0.768 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7669 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7669 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7658 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7657 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7657 |
Intermediate Similarity |
NPD7472 |
Approved |
0.764 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7633 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7614 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD5408 |
Approved |
0.761 |
Intermediate Similarity |
NPD5406 |
Approved |
0.761 |
Intermediate Similarity |
NPD5405 |
Approved |
0.761 |
Intermediate Similarity |
NPD6100 |
Approved |
0.761 |
Intermediate Similarity |
NPD5404 |
Approved |
0.761 |
Intermediate Similarity |
NPD6099 |
Approved |
0.76 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7597 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7574 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7547 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5402 |
Approved |
0.747 |
Intermediate Similarity |
NPD920 |
Approved |
0.7469 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7439 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7401 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD943 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7277 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7268 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7175 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD919 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7119 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7801 |
Approved |
0.707 |
Intermediate Similarity |
NPD2797 |
Approved |
0.707 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7062 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD37 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7016 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7011 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD4287 |
Approved |
0.6994 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.699 |
Remote Similarity |
NPD7584 |
Approved |
0.6983 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6974 |
Remote Similarity |
NPD8319 |
Approved |
0.6971 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6962 |
Remote Similarity |
NPD1164 |
Approved |
0.6961 |
Remote Similarity |
NPD7228 |
Approved |
0.6961 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6954 |
Remote Similarity |
NPD7577 |
Discontinued |
0.6949 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6948 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD6534 |
Approved |
0.6947 |
Remote Similarity |
NPD6535 |
Approved |
0.6941 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6935 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD4965 |
Approved |
0.6932 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD4966 |
Approved |
0.6928 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6899 |
Remote Similarity |
NPD1876 |
Approved |
0.6899 |
Remote Similarity |
NPD3225 |
Approved |
0.6894 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6889 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6883 |
Remote Similarity |
NPD9545 |
Approved |
0.6882 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6879
|
Remote Similarity |
NPD9717 |
Approved |